Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
- 1 November 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 352 (9139), 1498-1504
- https://doi.org/10.1016/s0140-6736(98)03334-0
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- New treatments for multiple sclerosisCurrent Opinion in Neurology, 1996
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Treatment of multiple sclerosisThe Lancet, 1994
- THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDYBrain, 1991
- Efficient Constitutive Production of Human Fibroblast Interferon by Hamster Cells Transformed with the IFN-β1Gene Fused to An SV40 Early PromoterDNA, 1984
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- Intensive Immunosuppression in Progressive Multiple SclerosisNew England Journal of Medicine, 1983
- NUCLEAR MAGNETIC RESONANCE IMAGING OF THE BRAIN IN MULTIPLE SCLEROSISThe Lancet, 1981